Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CompanionMx was a digital health company that specialized in the proactive monitoring of mental health through acoustic and behavioral biomarkers. Spun out from Cogito and based on research from Harvard Medical School and MIT Lincoln Laboratory, the company developed the Companion system, a smartphone-based platform that analyzed voice and phone usage patterns. This technology provided clinicians with objective, real-time insights into the mental states of patients suffering from depression and bipolar disorder. The company aimed to bridge the gap between clinical visits by identifying early warning signs of relapse through AI-driven analysis. CompanionMx was eventually re-integrated or acquired by its parent company, Cogito, which continues to utilize the underlying behavioral AI technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CompanionMx.